Literature DB >> 26951101

Natural Products Towards the Discovery of Potential Future Antithrombotic Drugs.

Md Asiful Islam1, Fahmida Alam, Md Ibrahim Khalil, Teguh Haryo Sasongko, Siew Hua Gan2.   

Abstract

Globally, thrombosis-associated disorders are one of the main contributors to fatalities. Besides genetic influences, there are some acquired and environmental risk factors dominating thrombotic diseases. Although standard regimens have been used for a long time, many side effects still occur which can be life threatening. Therefore, natural products are good alternatives. Although the quest for antithrombotic natural products came to light only since the end of last century, in the last two decades, a considerable number of natural products showing antithrombotic activities (antiplatelet, anticoagulant and fibrinolytic) with no or minimal side effects have been reported. In this review, several natural products used as antithrombotic agents including medicinal plants, vegetables, fruits, spices and edible mushrooms which have been discovered in the last 15 years and their target sites (thrombogenic components, factors and thrombotic pathways) are described. In addition, the side effects, limitations and interactions of standard regimens with natural products are also discussed. The active compounds could serve as potential sources for future research on antithrombotic drug development. As a future direction, more advanced researches (in quest of the target cofactor or component involved in antithrombotic pathways) are warranted for the development of potential natural antithrombotic medications (alone or combined with standard regimens) to ensure maximum safety and efficacy.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26951101     DOI: 10.2174/1381612822666160307150454

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  7 in total

1.  The evolution of recombinant thrombolytics: Current status and future directions.

Authors:  Yogender Pal Khasa
Journal:  Bioengineered       Date:  2016-10-03       Impact factor: 3.269

2.  Editorial: Frontier Views in Designing Therapeutic Candidates for Management of Diverse Diseases.

Authors:  Mohammad A Kamal; Nigel H Greig
Journal:  Curr Pharm Des       Date:  2017       Impact factor: 3.116

3.  Editorial (Thematic Issue: Managing Strategies for Diverse Diseases: Challenges from Bench to Bedside Translation in Successful Drug Discovery and Development (Part C)).

Authors:  Mohammad A Kamal; Nigel H Greig
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

4.  Editorial: Managing Strategies for Diverse Diseases: Challenges from Bench to Bedside Translation in Successful Drug Discovery and Development (Part B).

Authors:  Mohammad A Kamal; Nigel H Greig
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

Review 5.  Dietary Phytochemicals: Natural Swords Combating Inflammation and Oxidation-Mediated Degenerative Diseases.

Authors:  Md Asiful Islam; Fahmida Alam; Md Solayman; Md Ibrahim Khalil; Mohammad Amjad Kamal; Siew Hua Gan
Journal:  Oxid Med Cell Longev       Date:  2016-09-19       Impact factor: 6.543

6.  The Ovotransferrin-Derived Peptide IRW Attenuates Lipopolysaccharide-Induced Inflammatory Responses.

Authors:  Huanli Jiao; Qing Zhang; Yuanbang Lin; Ying Gao; Peng Zhang
Journal:  Biomed Res Int       Date:  2019-01-02       Impact factor: 3.411

Review 7.  Potential clinical applications of phytopharmaceuticals for the in-patient management of coagulopathies in COVID-19.

Authors:  Ashis K Mukherjee; Dhruba J Chattopadhyay
Journal:  Phytother Res       Date:  2022-02-11       Impact factor: 6.388

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.